Kremer, Wolfgang Maximilian; Koch, Sandra; Lochner, Dorothea et al.
Prospective assessment of sarcopenia as a prognostic factor for survival in patients with liver cirrhosisJOURNAL OF HEPATOLOGY. Bd. 70. 2019 S. E656-E657
Huber, Yvonne; Sivanathan, Visvakanth; Thieringer, Florian et al.
PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF TWO DIFFERENT WIRE TECHNIQUES FOR COLD SNARE POLYPECTOMYGASTROINTESTINAL ENDOSCOPY. Bd. 89. H. 6. 2019 S. AB389-AB389
Labenz, Christian; Toenges, Gerrit; Huber, Yvonne et al.
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathyALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2019
Finn, Richard S.; Kudo, Masatoshi; Kang, Yoon-Koo et al.
Ramucirumab (RAM) as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline alpha-fetoprotein (AFP): An analysis of AFP kinetics in the phase III REACH-2 study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 4. 2019
Llovet, Josep M.; Yen, Chia-Jui; Finn, Richard S. et al.
Ramucirumab (RAM) for sorafenib intolerant patients with hepatocellular carcinoma (HCC) and elevated baseline alpha fetoprotein (AFP): Outcomes from two randomized phase 3 studies (REACH, REACH2).JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019
Zhu, Andrew X.; Kang, Yoon-Koo; Yen, Chia-Jui et al.
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased alpha-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trialLANCET ONCOLOGY. Bd. 20. H. 2. 2019 S. 282-296
Zhu, Andrew X.; Finn, Richard S.; Galle, Peter R. et al.
Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of alpha-fetoproteinLANCET ONCOLOGY. Bd. 20. H. 4. 2019 S. E191-E191
Llovet, J.; Kudo, M.; Kang, Y-K. et al.
Ramucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysisANNALS OF ONCOLOGY. Bd. 30. 2019 S. 293-+
Kim, Yong Ook; Park, Kyoung-Sook; Schuessler, Christoph et al.
RAPIDLY PROGRESSIVE, POLYCLONAL ORTHOTOPIC HEPATOCELLULAR CARCINOMA (HCC) IN MDR2 (abcb4) KNOCKOUT MICE TREATED WITH DIETHYLNITROSAMINE AND PHENOBARBITALHEPATOLOGY. Bd. 70. 2019 S. 1208A-1209A
Goepfert, Katrin; Dinsart, Christiane; Rommelaere, Jean et al.
Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune SilencingFRONTIERS IN ONCOLOGY. Bd. 9. 2019